Business Description
Strides Pharma Science Ltd
ISIN : INE939A01011
Total Employee Number:
3,616Compare
Compare
Traded in other countries / regions
STAR.India IPO Date
2000-02-02Description
Strides Pharma Science Ltd is into the development and manufacture of pharmaceutical products. The company has single segment Pharmaceutical. Pharmaceutical segment represents the business of development, manufacture and Commercialization of pharmaceutical products other than biological drugs. It has presence in North America, Australia, Africa, Europe, and India. The company generates majority of revenue from North America.
Financial Strength
5/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Cash-To-Debt | 0.12 | |||||
Equity-to-Asset | 0.45 | |||||
Debt-to-Equity | 0.57 | |||||
Debt-to-EBITDA | 1.68 | |||||
Interest Coverage | 4.05 | |||||
Piotroski F-Score | 7/9 | |||||
Altman Z-Score | 2.93 | |||||
Beneish M-Score | -2.53 | |||||
WACC vs ROIC | ||||||
Growth Rank
4/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | 7.8 | |||||
3-Year EBITDA Growth Rate | 78.8 | |||||
3-Year Book Growth Rate | 11.2 |
Momentum Rank
6/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
5-Day RSI | 35.34 | |||||
9-Day RSI | 38.2 | |||||
14-Day RSI | 40.37 | |||||
3-1 Month Momentum % | 5.41 | |||||
6-1 Month Momentum % | 24.62 | |||||
12-1 Month Momentum % | 25.03 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Current Ratio | 1.25 | |||||
Quick Ratio | 0.68 | |||||
Cash Ratio | 0.07 | |||||
Days Inventory | 271.56 | |||||
Days Sales Outstanding | 90.68 | |||||
Days Payable | 219.32 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Dividend Yield % | 0.49 | |||||
Dividend Payout Ratio | 0.06 | |||||
Forward Dividend Yield % | 0.49 | |||||
5-Year Yield-on-Cost % | 0.49 | |||||
3-Year Average Share Buyback Ratio | -0.7 | |||||
Shareholder Yield % | 3.47 |
Profitability Rank
6/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Gross Margin % | 59.69 | |||||
Operating Margin % | 14.88 | |||||
Net Margin % | 11.45 | |||||
EBITDA Margin % | 21.6 | |||||
FCF Margin % | 5.86 | |||||
OCF Margin % | 14.46 | |||||
ROE % | 19.83 | |||||
ROA % | 8.56 | |||||
ROIC % | 12.65 | |||||
3-Year ROIIC % | -1618.85 | |||||
ROC (Joel Greenblatt) % | 34.88 | |||||
ROCE % | 22.86 | |||||
Years of Profitability over Past 10-Year | 7 |
GF Value Rank
3/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
PE Ratio | 16.99 | |||||
Forward PE Ratio | 15.78 | |||||
PE Ratio without NRI | 16.31 | |||||
Shiller PE Ratio | 16.39 | |||||
Price-to-Owner-Earnings | 18.78 | |||||
PS Ratio | 1.94 | |||||
PB Ratio | 3.04 | |||||
Price-to-Tangible-Book | 5.51 | |||||
Price-to-Free-Cash-Flow | 33.2 | |||||
Price-to-Operating-Cash-Flow | 13.45 | |||||
EV-to-EBIT | 13.03 | |||||
EV-to-EBITDA | 10.52 | |||||
EV-to-Revenue | 2.27 | |||||
EV-to-FCF | 38.8 | |||||
Price-to-GF-Value | 1.34 | |||||
Price-to-Projected-FCF | 2.27 | |||||
Price-to-Median-PS-Value | 2.12 | |||||
Price-to-Graham-Number | 2 | |||||
Earnings Yield (Greenblatt) % | 7.67 | |||||
FCF Yield % | 3.01 | |||||
Forward Rate of Return (Yacktman) % | -7.61 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Strides Pharma Science Ltd Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil ₹) | 48,586.83 | ||
| EPS (TTM) (₹) | 60.34 | ||
| Beta | 0.9848 | ||
| 3-Year Sharpe Ratio | 1.62 | ||
| 3-Year Sortino Ratio | 4.39 | ||
| Volatility % | 24.47 | ||
| 14-Day RSI | 40.37 | ||
| 14-Day ATR (₹) | 40.252309 | ||
| 20-Day SMA (₹) | 1063.18 | ||
| 12-1 Month Momentum % | 25.03 | ||
| 52-Week Range (₹) | 768.65 - 1231 | ||
| Shares Outstanding (Mil) | 92.17 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 7 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Strides Pharma Science Ltd Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Strides Pharma Science Ltd Stock Events
| Event | Date | Price (₹) | ||
|---|---|---|---|---|
| INR 5.000000 Cash Dividend | 2026-07-31 | 1,072.80 (+1.25%) | ||
| INR 4.000000 Cash Dividend | 2025-07-22 | 889.00 (+0.53%) | ||
| INR 2.500000 Cash Dividend | 2024-09-09 | 624.96 (+0.57%) |
Show
Entries
Strides Pharma Science Ltd Frequently Asked Questions
What is Strides Pharma Science Ltd(NSE:STAR)'s stock price today?
The current price of NSE:STAR is ₹1025.00. The 52 week high of NSE:STAR is ₹1231.00 and 52 week low is ₹768.65.
When is next earnings date of Strides Pharma Science Ltd(NSE:STAR)?
The next earnings date of Strides Pharma Science Ltd(NSE:STAR) is .
Does Strides Pharma Science Ltd(NSE:STAR) pay dividends? If so, how much?
The Dividend Yield %  of Strides Pharma Science Ltd(NSE:STAR) is 0.49% (As of Today), Highest Dividend Payout Ratio of Strides Pharma Science Ltd(NSE:STAR) was 0.71. The lowest was 0.06. And the median was 0.14. The  Forward Dividend Yield % of Strides Pharma Science Ltd(NSE:STAR) is 0.49%. For more information regarding to dividend, please check our Dividend Page.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Articles on Strides Pharma Science Ltd
No articles.
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers